Related Experiment Videos
[Sneddon syndrome: vasculitis or thrombotic disorder?]
S G Zipper1, S Lambert, W R Seemann
1Neurologische Klinik, St.-Katharinen-Krankenhaus.
Medizinische Klinik (Munich, Germany : 1983)
|April 20, 2000
Summary
Sneddon's syndrome (SNS), a disorder causing blood vessel occlusion, may not be a distinct disease. Differentiating primary from secondary SNS is key for effective treatment strategies.
Area of Science:
- Neurology
- Vascular Medicine
- Rheumatology
Background:
- Sneddon's syndrome (SNS) involves livedo reticularis generalisata (LR) and central nervous system (CNS) affection.
- It's a progressive systemic disorder characterized by small and medium vessel occlusion affecting skin, brain, kidneys, heart, and eyes.
- Etiology is unclear, but associations exist with antiphospholipid syndrome, vasculitis, and coagulopathies; hereditary and toxic factors may contribute.
Observation:
- A case report details a 56-year-old woman with dementia and hemiparesis preceded by LR.
- Diagnostic imaging (MRI, SPECT, TCD) revealed diffuse ischemic brain lesions consistent with small and medium vessel disease.
- Histopathology of brain, meninges, and skin was inconclusive, but lab findings suggested vasculitis.
Findings:
- Neurological deficits and livedo reticularis improved with immunosuppressive therapy (prednisolone, azathioprine).
- The case highlights the diagnostic challenges and potential therapeutic avenues for SNS.
- Vascular occlusion in SNS impacts multiple organ systems, necessitating a comprehensive diagnostic approach.
Implications:
- SNS may represent a spectrum of disease rather than a distinct nosological entity.
- Distinguishing between primary (idiopathic) and secondary SNS is crucial for tailoring therapeutic interventions.
- Further research into the pathogenesis and classification of SNS is warranted to optimize patient management.